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Histone H3.3 is a highly conserved histone H3 replacement variant in metazoans and has been implicated in many
important biological processes, including cell differentiation and reprogramming. Germline and somatic mutations
in H3.3 genomic incorporation pathway components or in H3.3 encoding genes have been associated with human
congenital diseases and cancers, respectively. However, the role of H3.3 in mammalian development remains un-
clear. To address this question, we generated H3.3-null mouse models through classical genetic approaches. We
found that H3.3 plays an essential role in mouse development. Complete depletion of H3.3 leads to developmental
retardation and early embryonic lethality. At the cellular level, H3.3 loss triggers cell cycle suppression and cell
death. Surprisingly, H3.3 depletion does not dramatically disrupt gene regulation in the developing embryo. Instead,
H3.3 depletion causes dysfunction of heterochromatin structures at telomeres, centromeres, and pericentromeric
regions of chromosomes, leading tomitotic defects. The resulting karyotypical abnormalities andDNA damage lead
to p53 pathway activation. In summary, our results reveal that an important function of H3.3 is to support chro-
mosomal heterochromatic structures, thus maintaining genome integrity during mammalian development.
[Keywords: histone H3.3; genome integrity; transcriptional regulation; cell proliferation; apoptosis;
mouse embryonic development]
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H3.3 differs from the canonical replication-coupled H3
histones (H3.1/H3.2 inmammals) by only four to five ami-
no acids, respectively, but has distinct expression patterns
and chromatin incorporation mechanisms. Canonical H3
variants are expressed only during S phase, and their in-
corporation is mediated by the CAF-1 chromatin assem-
bly complex (Smith and Stillman 1989; Verreault et al.
1996; Tagami et al. 2004). In contrast, H3.3 is expressed
throughout the cell cycle and is incorporated via a number
of different pathways, including the CHD1 and ATRX
chromatin remodeling complexes and the HIRA chaper-
one complex (Tagami et al. 2004; Konev et al. 2007; Drane
et al. 2010; Lewis et al. 2010).
H3.3 is unevenly distributed in the genome, suggesting
that it may have diverse roles. It is enriched in transcribed
genes, enhancers, regulatory elements, and also hete-
rochromatic repeats, including telomeres and pericen-
tromeric regions (Wirbelauer et al. 2005; Loyola and
Almouzni 2007; Goldberg et al. 2010; Szenker et al.
2011). A study with mouse embryonic stem (ES) cells
showed that the HIRA complex deposits H3.3 in tran-
scribed genes, while the ATRX complex delivers H3.3 to
telomeres and pericentromeric repeats (Goldberg et al.
2010).
H3.3 has been implicated in the epigenetic regulation
of diverse biological processes. When incorporated into
a nucleosome, H3.3 accumulates modifications associat-
ed with gene activation or open chromatin—including
methylation on K4, K36, and K79 and acetylation on K9
andK14—and is deprived of suppressivemodifications, in-
cluding K9 and K27 methylations (McKittrick et al. 2004;
Loyola and Almouzni 2007). H3.3-containing nucleo-
somes are intrinsically unstable and promote gene activa-
tion, especially with histone H2A.Z coincorporation (Jin
and Felsenfeld 2007; Jin et al. 2009; Chen et al. 2013).
H3.3 maintains the somatic epigenetic memory in nucle-
ar transferred Xenopus nuclei (Ng and Gurdon 2008) and
supports differentiation of cultured murine muscle pre-
cursor cells (Harada et al. 2012). HIRA-dependent incor-
poration of H3.3 is also required for the reprogramming
of nuclear transferred murine nuclei (Jullien et al. 2012;
Wen et al. 2014), DNA replication and rRNA transcription
inmouse zygotes (Lin et al. 2014), transcriptional recovery
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after genomic DNA damage in human cancer cell lines
(Adam et al. 2013), and Polycomb-repressive complex 2 re-
cruitment to developmentally regulated bivalent loci in
mouse ES cells (Banaszynski et al. 2013). Furthermore,
somatic mutations in H3.3-encoding genes cause various
types of cancer in humans, underscoring its role in main-
taining tissue homeostasis (Schwartzentruber et al. 2012;
Behjati et al. 2013).
H3.3 is highly conserved across metazoans (Elsaesser
et al. 2010; Szenker et al. 2011; Waterborg 2012), and its
in vivo function has been studied in a number of different
model organisms. InDrosophila, H3.3 is required only for
fertility but is dispensable for both embryonic and postna-
tal development (Hodl and Basler 2009; Sakai et al. 2009).
The fertility defects in H3.3-null flies can be rescued by
ectopic expression of H3.2 (Hodl and Basler 2012). Like-
wise, growth defects of H3.2-null somatic clones can be
rescued by overexpression of H3.3 in S phase (Hodl and
Basler 2012), indicating that only the overall level of H3
histone, but not any specific variant, is essential in fly de-
velopment. InXenopus, HIRA-dependent H3.3 deposition
is specifically required for early gastrulation andmesoder-
mal marker gene activation, and, importantly, H3.2 over-
expression cannot rescue the mutant phenotype (Szenker
et al. 2012). XenopusH3.3 promotes mesodermal gene ac-
tivation by suppressing linker histone H1 incorporation
and thus counterbalancing its chromatin-compacting ef-
fect, and an optimal ratio of the two is required to main-
tain a competent chromatin state for gastrulation to
proceed (Lim et al. 2013). In zebrafish, reduced levels of
H3.3 in the nuclei, caused by an aggregating dominant
mutant H3.3, leads to defects in cranial neural crest cell
differentiation (Cox et al. 2012), indicating tissue-specific
sensitivity of H3.3 reduction in fish development.
As in flies and humans, the murine H3.3 protein is re-
dundantly encoded by two genes:H3f3a andH3f3b. Single
knockouts and knockdowns of these two genes in mice
have been reported (Couldrey et al. 1999; Bush et al.
2013; Lin et al. 2013; Tang et al. 2013, 2015; Inoue and
Zhang 2014; Yuen et al. 2014). However, no one has re-
ported a double knockout for both genes in themouse em-
bryo to reveal more fundamental functions of H3.3 in
mouse development. Homozygotes of a H3f3a hypomor-
phic gene trap-inserted allele (Couldrey et al. 1999) and a
targeted H3f3a-null allele (Tang et al. 2013) had reduced
viability and male subfertility/infertility phenotypes.
H3f3b knockout mice also have reduced viability, and
surviving adults are infertile (Bush et al. 2013; Yuen
et al. 2014); even heterozygous males were reported to
be infertile (Tang et al. 2013, 2015). Different phenotypes
were observed in H3.3 knockdown mouse zygotes using
different approaches; a nuclear envelope formation defect
was observed in a study using siRNA, and a chromosome
condensation changewas observed in another study using
morpholinos (Lin et al. 2013; Inoue and Zhang 2014).
However, the knockdown experiments come with cave-
ats. Both of these early stage phenotypes can be attributed
to paternal genome nucleosome assembly defects during
the histone–protamine exchange process after fertiliza-
tion (Inoue and Zhang 2014) rather than an H3.3-specific
effect. Furthermore, the off-target effects associated with
either approach also render the conclusions less definitive
(Jackson and Linsley 2010; Kok et al. 2015). Therefore, the
role of H3.3 in mammalian development remains elusive.
In order to study H3.3’s role in mouse development, we
generated new targeted alleles for H3f3a and H3f3b in
mice. In contrast to previous findings, our single-knock-
out mice, regardless of the gene, were overtly normal
and fertile in both sexes. Complete depletion of H3.3
with double knockouts results in developmental retarda-
tion and embryonic lethality. H3.3-null embryos show
reduced cell proliferation and increased cell death. Abla-
tion of H3.3 in mouse ES cells leads to cell death and
mitotic defects. The growth retardation phenotype can
be rescued by a p53 deletion. Transcriptional profiling
of these p53-null-rescued H3.3-null embryos by RNA se-
quencing (RNA-seq) revealed only limited changes to the
global transcriptome. H3.3-null mouse embryonic fibro-
blasts (MEFs) without p53 can proliferate but show
mitotic abnormalities associated with defects in chromo-
somal heterochromatic structures and genome instability
phenotypes. Taken together, our data suggest that a major
function of H3.3 inmammalian development ismaintain-
ing genome integrity through its function in supporting
heterochromatin structures at telomeres, centromeres,
and pericentromeric regions.
Results
H3.3 complete null leads to peri-implantation lethality,
while perinatal lethality and male infertility occur in
compound mutants
To guide our search for phenotypes, we first conducted
expression analysis in various adult organs in wild-type
mice for H3f3a, H3f3b, and, for comparison, H3.1/3.2-
encoding genes and stem–loop-binding protein (SLBP;
which is expressed during S phase to facilitate the transla-
tion of polyA-less histone genes) (Whitfield et al. 2000).
Both H3f3a and H3f3b genes are ubiquitously expressed
but differ in levels among tissues and are uncoupled
from the expression of canonical H3 histones (Fig. 1A).
The highest expression of both genes occurs in the testis,
followed by the ovary. Canonical H3 expression is more
associated with cell proliferation status; the thymus,
with actively dividing immune cells, has the highest level
of H3.1/H3.2 expression. SLBP is also highly expressed in
the reproductive and immune systems. The data suggest a
special role for H3.3 in germ cell development.
We targeted theH3f3a andH3f3b genes via homologous
recombination in mouse ES cells using the same strategy
for both: We inserted a promoter-less, splice acceptor–
Neo-positive selection cassette with a conditional report-
er gene (EGFP forH3f3a, and tdTomato forH3f3b) into in-
tron 1 (Fig. 1B; see Supplemental Fig. S1 for details) and
flanked the first coding exon (exon 2) with loxP sites.
Upon Cre-mediated deletion, the next available in-frame
ATG produces a 16-amino-acid peptide (the full-length
H3.3 has 136 amino acids), creating a functionally null al-
lele. Correctly targeted clones were identified by PCR
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screens and reconfirmed with Southern blots (Supple-
mental Fig. S2). Mutant mice were generated through
blastocyst injection. For both genes, the resulting gene
trap allelewas successfully transmitted through the germ-
line and converted to a fluorescent protein reporter allele,
a conditional allele, and a null allele by exposure to re-
combinases in vivo through crosses (Fig. 1B). The reporter
alleles revealed ubiquitous expression of both genes dur-
ing embryonic development (Fig. 1C). The gene-disrupt-
ing function of each allele was verified by transcription
analysis in select organs from homozygous adult animals
(Fig. 1D). The null allele completely abolishes expres-
sion of exon 2, and, importantly, the intronic insertions
of FRT/loxP sites do not impede normal transcription or
splicing through the introns, allowing for conditional dele-
tion of H3.3 genes.
Single-gene knockout (H3f3a−/− or H3f3b−/−) mice are
overtly normal and fertile (data not shown). Furthermore,
they can generate healthy and fertile progeny (in H3f3a−/
−×H3f3a−/− or H3f3b−/−×H3f3b−/− crosses), indicating
that neither gene is required for the complete mouse life
cycle.
To generate H3.3 complete null mutants, we inter-
crossed double-heterozygous animals (H3f3a−/+; H3f3b−/+).
Different staged embryos and postnatal pups were collect-
ed, and the distribution of their genotypes is summarized
in Figure 2A. At the late blastocyst stage (embryonic day
3.5 [E3.5]), H3f3a−/−; H3f3b−/− double-knockout embryos
were recovered at the expected Mendelian ratio. They
were morphologically indistinguishable from control lit-
termates (Fig. 2B). However, at E6.5, ∼2 d after implanta-
tion, double-knockout mutants were almost completely
absent. The single double-knockout mutant recovered,
of eight expected from 123 embryos, showed retarded
growth (Fig. 2B). At E8.5, only two double-knockout mu-
tants, of 12 expected, were recovered from 198 embryos.
Similarly, these mutants had delayed growth. They mor-
phologically resembled E7.5 wild-type embryos and had
initiatedBrachyury expression, amesodermmarker (Herr-
mann 1991), indicating the correct progression of cell dif-
ferentiation and patterning in double-knockout mutants
(Fig. 2B). No double-knockout embryo was found at later
stages. The low recovery rate and the phenotypes of dou-
ble-knockout embryos after E6.5 indicatemost of them ei-
ther fail to implant or die shortly after due to a growth
defect.
Compound mutants from the same crosses described
above had other phenotypes.H3f3a−/−; H3f3b−/+ mutants
(ANullBHet) die perinatally. All ANullBHet pups identified

















































































































































































Figure 1. H3.3 gene expression and generation of
H3.3 alleles. (A) Expression of H3f3a, H3f3b, H3.1/
3.2, and SLBP in wild-type C57BL/6 adult mouse or-
gans by quantitative PCR (qPCR). H3.1/H3.2 level
was detected by using primers amplifying the consen-
sus region of all of the annotated H3.1/H3.1-encoding
gene copies in the mouse genome. Levels of individu-
al genes across tissues were normalized to 18S rRNA,
with the highest level set to 100. (B) Diagram of mu-
tant H3f3a and H3f3b alleles created in this study.
The initial targeted alleles were gene trap alleles
with a splice acceptor and a polyA signal in intron
1. Fluorescent reporter alleles (EGFP for H3f3a, and
tdTomato for H3f3b) were generated by ϕC31 inte-
grase-mediated recombination between AttP and
AttB sites. Null alleles were created by Cre-mediated
deletion of the critical first coding exon (exon 2). Con-
ditional (flox) alleles were created by deleting the
gene trap cassette with FLP-mediated recombination
between FRT sites. (NEO) Neomycin/G418 resis-
tance gene. (C ) Expression of fluorescent reporter al-
leles. A reporter allele carrier embryonic day 10.5
(E10.5) embryo is shown with a wild-type littermate
for either gene. (D) Expression ofH3f3a andH3f3b al-
leles in brain (cerebellum), spleen, and testis tissue
from wild-type (WT; C57BL/6) and mutant animals
homozygous with the indicated alleles by qPCR.
Primer sets spanning intron 1 (exons 1 and 2) and in-
tron 2 (exons 2 and 3) of each genewere used to access
the transcription and splicing efficiency through in-
trons 1 and 2, respectively. The standard error of the
mean (SEM) is from two biological replicates (n = 2)
for both A and D.
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and their number was significantly lower than expected.
When pups were delivered by C-section at E18.5, 1 d be-
fore birth, ANullBHet mutants were found at the expected
Mendelian ratio (Fig. 2A). However, they usually ap-
peared smaller and weighed less than their wild-type lit-
termates (Fig. 2C). In contrast to their littermates, most
ANullBHet mutants could not breathe properly and died
(Fig. 2D), albeit having normal gross morphology (data
not shown).
H3f3a−/+; H3f3b−/− mutant (AHetBNull) males are infer-
tile. AHetBNull mice were born at the expected Mendelian
ratio and survived to adulthood. However, they appeared
slightly smaller than their littermates before weaning
(data not shown). The mutant males could mate and pro-
duce vaginal plugs, but thematedwild-type females never
became pregnant. Sections of AHetBNull testes revealed
complete loss of germ cells (Fig. 2E). AHetBNull females
are fertile (data not shown).
H3.3 deletion leads to reduced cell proliferation
and increased cell death in the embryo
While double-knockout blastocysts appeared normal, pos-
sibly due tomaternal deposits of H3.3mRNAand protein,
the post-implantation stage double-knockout embryos,
which have more obvious phenotypes, were very rare.
To facilitate the study of H3.3 function in embryonic de-
velopment, we used a conditional knockout approach to
deplete H3.3 in the embryo with a Sox2-Cre transgene
(Hayashi et al. 2002). When the transgene is transmitted
through the paternal germline, Cre expression starts at
the blastocyst stage in the inner cell mass, inducing global
deletion of floxed alleles in the whole embryo. We crossed
homozygous double-floxed females (H3f3afl/fl; H3f3bfl/fl)
to double-heterozygous males with the Cre transgene
(H3f3a−/+;H3f3b−/+; Sox2-CreTg/0) and harvested embryos
at different time points. With this approach, H3.3 deple-
tion occurs later than in the double-knockout crosses, re-
sulting in later manifestation of mutant phenotypes.
Indeed, we recovered H3.3 conditional knockout (cKO)
mutant embryos (H3f3afl/−; H3f3bfl/−; Sox2-CreTg/0, re-
ferred to as Sox2-cKO hereafter) at the expected Mende-
lian ratio up to E10.5. After E10.5, most mutants were
resorbed or being resorbed (data not shown). Sox2-cKO
embryos were developmentally retarded at every time
point examined (Fig. 3A). They appeared to grow in size,
albeit without turning, but continuously fell behind their
littermates as gestation proceeded. The overall patterning
and cell differentiation, however, appears normal in Sox2-
cKO embryos, as judged by their morphology and Bra-
chyury expression pattern visualized by whole-mount in
situ hybridization at E8.5 (Fig. 3B). Notably, every Sox2-
A
B E8.5E3.5
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Figure 2. Lethality and fertility phenotypes of H3.3
gene knockoutmutants. (A) The number of embryos/
pups of specific genotypes observed at different stages
from H3f3a−/+; H3f3b−/+ mouse intercrosses. Num-
bers in parenthesis are expected numbers at theMen-
delian ratio. The red background indicates that the
observed numbers were significantly lower than ex-
pected. All of the AnullBhet pups died after birth. Sig-
nificant differences from the expected numbers are
indicated by (∗) P < 0.05 and (∗∗) P < 0.01 in χ2 test.
(B) Double-knockout embryos (H3f3a−/−; H3f3b−/−)
and their littermate control (H3f3a−/+; H3f3b−/+) at
different stages. E8.5 embryos were hybridized with
Brachyury probe, showing expression at the tail (ar-
row) and notochord (arrowhead) in the control and
presumably the primitive streak in the double-
knockoutmutant (arrow). (C ) Box plot of bodyweight
distribution of E18.5 C-sectioned embryos. Raw val-
ues were first normalized to the average weight in
the litter. Significant difference from wild type (WT)
is indicated. (∗∗∗) P < 0.001 in ANOVA test. (D) Sur-
vival of C-sectioned E18.5 embryos. Shown are total
numbers of observed embryos (blue bars) and those
that did not survive after C-section (red bars) in
each genotype group. (E) Hematoxylin and eosin
(H&E) sections of testes from 6- to 8-mo-old adult
males of the indicated genotypes.
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cKO embryo that we identified up to E10.5 had a beating
heart at the time of dissection, suggesting that H3.3-null
cells can differentiate properly.
We examined cell death and proliferation in Sox2-cKO
mutants to identify the underlying cause of the growth re-
tardation phenotype. Lysotracker staining detects acidifi-
cation of cellular compartments, which correlates with
occurrence of cell death (Fogel et al. 2012). Sox2-cKOmu-
tants showed dramatically elevated signal in the whole
embryo (Fig. 3C), indicating globally increased ectopic
cell death. The BrdU incorporation assay gauges cell pro-
liferation by staining cells that have gone through S phase
during the short pulse period and had BrdU incorporated
in their genomicDNA. Sox2-cKOmutants showed a near-
ly complete absence of positive signal, in stark contrast
to the ubiquitous strong staining of the controls (Fig.
3D), indicating strong cell cycle arrest or delay in H3.3-
null cells. Altogether, these data suggest that globally in-
creased cell death and decreased cell proliferation contrib-
ute to the developmental retardation phenotype of the
mutant embryos.
H3.3 depletion leads to cell death and mitotic
defects in ES cells
Weestablished conditional knockout ES cell lines with an
inducible Cre transgene, CAG-CreER (Hayashi and
McMahon 2002), with genotype: H3f3afl/−; H3f3bfl/−;
CAG-CreERTg/0 (referred to as CreER-cKO) to study the
cellular functions of H3.3. Upon 4-hydroxy-tamoxifen
(TAM) treatment, Cre efficiently deleted the floxed al-
leles, and the cells quickly lost their H3.3 expression at
both mRNA and protein levels (Fig. 4A,B).
H3.3 deletion triggered rapid cell death (Fig. 4C). When
we attempted to expandH3.3 CreER-cKO cells after TAM
treatment, the subsequent passages only resulted in cells
with incomplete H3.3 deletion rapidly taking over (data
not shown). This indicates that H3.3-null ES cells are
scale bar = 500 µm


























































Figure 3. Sox2-cKO embryos died due to increased
cell death and decreased cell proliferation. (A) Embry-
os at different stages from crosses between H3f3afl/fl;
H3f3bfl/fl females and H3f3afl/+; H3f3bfl/+; Sox2-
CreTg/0 males. For each stage, a control littermate
(H3f3afl/+; H3f3bfl/+; Sox2-CreTg/0) is shown with a
Sox2-cKOmutant. (B) Brachyury expression detected
by whole -mount in situ hybridization. Both the con-
trol and the Sox2-cKO mutant showed expression at
the tail (arrow) and notochord (arrowhead). (C ) E8.5
embryos stained with Lysotracker. Scattered positive
spots in the control are indicated (arrowheads). (D)
BrdU staining of sagittal sections of control and
Sox2-cKOE9.5 embryos. The faint cytoplasmic signal
in the Sox2-cKO/BrdU embryo section comes from
nonspecific background staining.
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either not viable or have a severe growth disadvantage. In-
terestingly, we observed sharply increased incidence of
mitotic abnormalities in H3.3 CreER-cKO ES cells, in-
cluding anaphase bridges and lagging chromosomes (Fig.
4D,E), indicating the involvement of mitotic failure in
the cause of cell death.
The p53 pathway mediates H3.3 mutant phenotypes
With themitotic phenotype in H3.3-null ES cells, we sus-
pected the involvement of the p53 pathway in the mani-
festation of H3.3 knockout phenotypes and examined
the expression of known p53 target genes p21 and Puma,
involved in controlling cell senescence and apoptosis, re-
spectively (Fig. 5A). Markedly, p21/Waf1, a tumor sup-
pressor gene that induces cell cycle arrest (Warfel and
El-Deiry 2013), is highly elevated in Sox2-cKO embryos
at E8.5. Puma/BBC3, a BH3-only Bcl-2 family proapop-
totic subclass gene (Hikisz and Kilianska 2012), is also
up-regulated. These results indicate that, in Sox2-cKO
mutants, the p53 pathway is activated and triggers cell cy-
cle arrest and cell death through its downstream targets.
To provide further evidence of p53 involvement, we at-
tempted to rescue the Sox2-cKO phenotypes by incorpo-
rating a p53-null mutation (Jonkers et al. 2001) into our
conditional knockout crosses. The p53-null background
dramatically rescued the Sox2-cKO mutant growth retar-
dation phenotype up to E11.5, which was the latest stage
they survived. Although there was some variation in the
extent of rescue, the majority of H3f3afl/−; H3f3bfl/−;
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Figure 4. Cell death and mitotic defects in H3.3 knockout (KO)
ES cells. (A)H3f3a andH3f3b expression in TAM-treated control
(H3f3afl/+;H3f3bfl/+;CAG-CreERTg/0) andCreER-cKOES cells de-
tectedbyRT-qPCR.SEMis fromtwobiological replicates. (B)H3.3
protein levels in control and CreER-cKO ES cells with or without
TAMdetectedbyWesternblot.Thenumbersbelowarecalculated
relative protein levels normalized to total H3. (C ) Representative
images of control and CreER-cKO ES cells with or without TAM
treatment. Equal numbers of cells were seeded for each group at
the beginning. (D) Mitotic abnormalities with anaphase bridges
(red arrow), lagging chromosomes (yellow arrowhead), or both
were observed in H3.3 knockout ES cells. Cells were fixed and
stainedwithDAPI. (E) Percentagesofmitotic cellswithabnormal-
ities in control andH3.3 knockout ES cells; two lines of eachwere
analyzed. Control is TAM-treated control cells. Twenty-five mi-








































Figure 5. p53 involvement in mediating the H3.3 knockout
phenotype. (A) Expression of H3f3a, H3f3b, p53, and two p53
target genes (p21 and Puma) in E8.5 embryos with the indicated
genotypes. SEM is from two biological replicates. Significant dif-
ference from control in the Sox2-cKO is indicated. (∗) P < 0.05;
(∗∗) P < 0.01 in one-tailed t-test. (B) E10.5 littermates with con-
trol–p53null (H3f3afl/+; H3f3bfl/+; Sox2-CreTg/0; p53−/−), Sox2-
cKO–p53−/+ (H3f3afl/−; H3f3bfl/−; Sox2-CreTg/0; p53−/+), or
Sox2-cKO–p53null (H3f3afl/−; H3f3bfl/−; Sox2-CreTg/0; p53−/−) ge-
notypes from a cross between a H3f3afl/fl; H3f3bfl/fl; p53−/+ fe-
male and a H3f3a−/+; H3f3b−/+; Sox2-CreTg/0; p53−/− male.
Neural tube disclosure in Sox2-cKO–p53null is indicated (arrow-
head); the two images below show the arrowhead-indicated re-
gion (yellow asterisk) from different angles.
Jang et al.
1382 GENES & DEVELOPMENT
were slightly smaller than their control littermates, with
morphologically normal body structures and organs.
However, neural tube closure defects were always ob-
served in these rescued embryos (Fig. 5B). This dramatic
rescue illustrates the pivotal role that p53 plays in H3.3
knockout phenotypes. However, the p53-null rescue did
not fully support development to later stages; we observed
resorptions of Sox2-cKO–p53nullmutants and a sharp drop
in their ratio after E10.5 (data not shown).
Limited changes in the global transcriptome
upon loss of H3.3
To understand the role that H3.3 plays in transcriptional
regulation, we examined the gene expression profiles
of the Sox2-cKO–p53null rescued embryos by RNA-seq.
Three mutant (H3f3afl/−; H3f3bfl/−; Sox2-CreTg/0;
Trp53−/−) and three control (H3f3afl/+; H3f3bfl/+; Sox2-
CreTg/0; Trp53−/−) E10.5 male embryos were used in the
sequencing experiment (Supplemental Fig. S3A). The tar-
geted second exon’s expression is completely abolished
for both H3f3a and H3f3b genes, as shown in the Univer-
sity of California at Santa Cruz (UCSC) Genome Browser
RNA-seq tracks (Supplemental Fig. S3B).
Because H3.3 is enriched in all transcribed genes (Wir-
belauer et al. 2005; Goldberg et al. 2010; Szenker et al.
2011), we expected a large number of them to show signif-
icant changes in expression. After mapping the reads to
the mouse reference genome (mm9), we identified close
to 14,000 expressed genes (defined as a gene with more
than one count permillion [CPM] in two ormore samples)
(Supplemental Tables S1, S2). Amultidimensional scaling
(MDS) plot showed that the H3.3-null and control embry-
os formed separate clusters, indicating that the two groups
have distinctive gene expression patterns (Supplemental
Fig. S3C). However, only ∼5% of the transcribed genes
showed statistically significant changes (with false dis-
cover rate [FDR] < 0.05 cutoff) (Fig. 6A), and their distribu-
tion was tilted toward the genes with lower expression
levels compared with the total population (Supplemental
Fig. S3D). Among the genes significantly changed, ∼65%
of them had a less than twofold difference, suggesting
minimal biological effects (Fig. 6B). More genes were up-
regulated in theH3.3-null embryos (∼66%of significantly
changed genes) (Fig. 6B). In addition, most of the more se-
verely affected genes, with greater than twofold differenc-
es, had relatively low expression levels (Supplemental Fig.
S3E).
Because the RNA-seq analysis method (edgeR) normal-
izes for total read counts in each library, it cannot detect
global expression shifts; e.g., a down-regulation of all tran-
scribed genes in the H3.3-null embryos. To rule out this
possibility, we selected six genes that did not show signif-
icant differences in the RNA-seq analysis and spanned a
wide range of CPMs for RT-qPCR validation. The results
were consistent with the RNA-seq analysis and showed
that there was not a global expression shift (Supplemental
Fig. S3F). Furthermore, therewere no significant differenc-
es in total RNAoutput per embryo between theH3.3-null
and control embryos (Supplemental Fig. S3G). Therefore,










































































































Figure 6. Differential expression analyses of H3.3-
null embryos in a p53-null background. (A) The edg-
eR smear plot visualization of RNA-seq results. Each
dot represents a gene; the X-axis is mean log2 CPM,
indicating expression level of the genes, and the Y-
axis is log2 fold change (log2FC), indicating gene ex-
pression change uponH3.3 deletion.Geneswith a sig-
nificant change (FDR < 0.05) are plotted in red. The
horizontal dashed blue lines mark the plus or minus
twofold change range. (B) Effect size distribution of
significantly changed genes. Sixty-five percent of
genes have changes between plus and minus twofold,
and 66% of genes have positive changes. (C, panel i)
Gene structure of Cdkn2a (cyclin-dependent kinase
inhibitor 2A); two splice isoforms, Ink4a and Arf,
are driven by different promoters and have different
first exons (1α and 1β, respectively). (Panel ii) Relative
expression levels of H3f3a, H3f3b, H3.1/3.2, Arf (de-
tected by primers spanning exons 1β/2), Ink4a (de-
tected by primers spanning exons 1α/2), and Cdkn2a
total output (detected by primers spanning exons
2/3) in H3.3 knockout (KO) versus control embryos.
n = 3. (∗) P < 0.05 in one-tailed t-test.
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we can rule out the possibility of a global and proportional
up-regulation/down-regulation of every gene in the H3.3-
null embryos. To determine whether transcription in
specific genomic domains was susceptible to loss of
H3.3, we examined the genomic distribution of signifi-
cantly changed genes (Supplemental Fig. S3H), expecting
to find down-regulated and up-regulated genes in separate
clusters. However, we could not find any specific patterns
and ruled out localized gene expression changes.
A recent report proposed a role for H3.3 in the silenc-
ing of endogenous retroviral elements in mouse ES cells
(Elsasser et al. 2015); therefore, we specifically examined
the expression of repetitive elements (REs) in our RNA-
seq data. However, statistical analysis did not find clear
separation between the control and H3.3 mutant embry-
os by their RE expression patterns (Supplemental Fig.
S3I). Furthermore, among the >1000 REs found expressed
in the embryos, only one element [“(A)n” element]
showed a statistically significant change in the mutant
embryos (Supplemental Fig. S3J; Supplemental Table
S3). Therefore, H3.3’s effect on the expression or suppres-
sion of REs in the developing embryo appears to be
minimal.
Intriguingly, Cdkn2a (cyclin-dependent kinase inhibi-
tor 2A), an important tumor suppressor gene (Kim and
Sharpless 2006), was the second most highly up-regulated
gene in the RNA-seq data analysis (the most up-regulated
gene, leading by a very small margin of fold change, was a
pseudogene) (Supplemental Table S2). Cdkn2a has two
transcriptional isoforms produced by alternative promot-
er usage: The α promoter produces the Ink4a transcript,
while the β promoter leads toArf expression (Fig. 6C, pan-
el i). We confirmed the up-regulation of Cdkn2a by RT-
qPCR. Specific primers were designed to gauge Arf- or
Ink4a-specific expression or the total output of both tran-
scripts. The results indicated that both transcription iso-
forms were up-regulated to similar levels in H3.3
knockout embryos relative to the control (Fig. 6C, panel
ii). At the same time, we confirmed the complete deletion
of H3.3 genes. We also examined the level of canonical
H3, whichwas reported to be up-regulated inH3.3mutant
flies (Hodl and Basler 2009), but found no change.
The biological effects of the gene expression changes
were analyzed by the Ingenuity Pathway Analysis soft-
ware (http://www.ingenuity.com), with a FDR < 0.05
cutoff. The canonic pathway (Supplemental Fig. S4; Sup-
plemental Table S4) and disease and biofunction pathway
(Supplemental Fig. S5; Supplemental Table S5) analyses
suggested that the hematological and immune system de-
velopment is most likely affected by these changes.
H3.3 depletion leads to mitotic defects
and genome instability
The p53-null mutation enables derivation of H3.3 knock-
out/p53null MEF lines (from Sox2-cKO–p53nullembryos).
H3.3-null MEFs derived from Sox2-cKO embryos with
wild-type p53 grew very poorly and were extremely diffi-
cult to expand (data not shown). In contrast, H3.3 knock-
out/p53null MEFs grew well and were easily expanded,
albeit slightly less proliferatively than MEFs derived
from the control littermates. These robustly growing
H3.3-nullMEFs allowed us to explore themechanisms be-
hind the H3.3 depletion-triggered cell death and growth
arrest. We used only early passage MEFs (passage 2 [P2]
to P5) in our experiments to minimize the effect of the
in vitro culture environment.
Interestingly, similar to the H3.3 knockout ES cells,
H3.3 knockout MEFs showed dramatically increased mi-
totic defects, including lagging chromosomes and ana-
phase bridges (Fig. 7A,B). To test for the involvement of
ATRX in the phenotype for its role in maintaining hetero-
chromatic chromosome structures, we performed fluores-
cent in situ hybridization (FISH) with a telomeric probe
and immunofluorescence with an antibody against
ATRX. ATRX localization to the pericentrimetric hete-
rochromatin appeared to be unaffected by loss of H3.3
even on the lagging chromosomes (Fig. 7A). We also per-
formed chromatin immunoprecipitation (ChIP) to assess
ATRX binding to telomeric sequence repeats in H3.3
knockout/p53nullMEFs but observed no change compared
with controls (Supplemental Fig. S6). In the mitotic cells
with anaphase bridges, we observed telomere FISH signals
in the middle of the bridging chromosomes (Fig. 7A), indi-
cating dicentric chromosomes formed through telomeric
fusions.
Wemademetaphase spreads and found dramatically in-
creased numbers of cells with abnormal numbers of chro-
mosomes in H3.3 knockout/p53null MEFs (Fig. 7C). The
majority of themhave chromosome gains. Loss ofH3.3 ap-
pears to cause polyploidy and aneuploidy, presumably re-
sulting from the faulty mitotic processes (Davoli and de
Lange 2011; Ganem and Pellman 2012).
Finally, we observed elevated levels of S139 phosphory-
lation of histone H2A.X (rH2A.X) in H3.3 knockout/
p53nullMEFs (Fig. 7D,E), a canonicalmarker for DNAdou-
ble-strand breaks (Rogakou et al. 1998). This indicates in-
creased DNA damage in H3.3 knockout cells.
H3.3 is required for normal heterochromatin
function at telomeres, centromeres,
and pericentromeric regions
To find the underlying cause of the mitotic defects in
H3.3-null MEFs, we examined the integrity of telomeres,
distribution of heterochromatic histone marks, and chro-
matin compaction at the telomeres, centromeres, and
pericentromeric regions where H3.3 was reported to be
enriched.
To determine whether H3.3 knockout/p53null MEF
lines had aberrant telomere sister chromatid exchange
(tSCE), we applied the chromosome orientation FISH
(CO-FISH) technique (Williams et al. 2011). Significantly
increased rates of tSCE events were observed in the
H3.3-null MEFs (Fig. 8A,B), indicating excessive recombi-
nation events in telomeres as a result of compromised
telomere structure or maintenance mechanisms (Bailey
et al. 2004).
Changes in local histone marks can compromise the
functions of telomeres and centromeres (Jones et al.
Jang et al.
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2008; O’Sullivan et al. 2014). Therefore, we also examined
changes in the characteristic histone marks, including
dimethylation at H3K9 and H3K79 and trimethylation
at H3K9 and H3K36 (Jones et al. 2008; Chantalat et al.
2011), at pericentromeric (major satellite) and centromer-
ic (minor satellite) regions and telomere repeats with
ChIP-qPCR assays. No dramatic changes were found at
the satellite repeats; however, there was a general trend
of reduced H3K9 trimethylation and significant reduction
of H3K36 dimethylation marks at the telomere (Fig. 8C).
When global levels of these marks in H3.3-null cells
were examined byWestern blotting, we did not see a stat-
istically significant reduction in any of the histonemarks,
but a general reduction of all of the marks was observed
(Supplemental Fig. S7A,B).
Heterochromatin compaction at telomeres, centro-
meres, and pericentromeric regions plays an essential
role for their functional integrity (Lange et al. 2013; Epis-
kopou et al. 2014). To quantitatively measure the com-
pactness of chromatin at these regions, we used the
formaldehyde-assisted isolation of regulatory elements
(FAIRE) technique, which is a sensitive method for de-
tecting open chromatin regions in the genome (Giresi
et al. 2007). In the FAIRE procedure, by chemical cross-
linking, mechanical shearing, and organic extraction, nu-
cleosome-free genomic DNA is enriched in the extract.
H3.3-null cells always produced slightly higher yield
than the controls (Supplemental Fig. S7C). This may be
an indicator of more open chromatin regions in the ge-
nome. We used qPCR to quantify the relative enrichment
of telomeric, centromere, and pericentromeric repeat se-
quences in each extract sample and found a significant
increase in FAIRE signal with the H3.3-null cells (Fig.
8D). This indicates that the heterochromatin at these re-
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Figure 7. Mitotic defects, karyotypic abnormality,
and DNA damage in H3.3 knockout (KO)/p53null
MEFs. (A) Mitotic abnormalities of H3.3 knockout/
p53null MEFs. ATRX immunofluorescence signal on
lagging chromosomes (arrows) and telomere FISH sig-
nal (TelC) in themiddle of bridging chromosomes (ar-
rowheads) are indicated. (B) Percentages of mitotic
cells with abnormalities in control and H3.3 knock-
out/p53null MEFs. Twenty-five mitotic events were
scored in each line. (∗∗) P < 0.01 in χ2 test. (C ) Distribu-
tion of chromosome numbers counted in metaphase
spreads made from H3.3 knockout/p53null MEF lines
(bottom) and their littermate control lines (top). Col-
ors denote close to normal 2N (40) counts (green), 4N
(80) counts (yellow), and 8N (160) counts (red). (D)
rH2A.X levels in H3.3 knockout/p53null and control
MEFs by Western blot. Lanes 2 and 4 are mutant
cell lines, and lanes 1 and 3 are their littermate con-
trol lines, respectively. (E) Relative expression levels
of H3.3 and rH2A.X calculated from D, normalized
to total H3 level. (∗) P < 0.05 in one-tailed t-test.
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To further investigate the possible causes of the cen-
tromeric and telomeric abnormalities in H3.3-null cells,
we examined the expression levels and site-specific en-
richments of centromeric histone H3 variant CENP-A,
H3K4 dimethylation, and the double-stranded telomeric
repeat-binding proteins TRF1 and TRF2. CENP-A defines
centromere identity, and its incorporation is partly
through replacing the so-called “placeholder” centromer-
ic H3.3 during G1 phase (Dunleavy et al. 2011). H3K4
dimethylation is found between CENP-A nucleosome
blocks (Sullivan and Karpen 2004). Thus, depletion of
H3.3 could result in a reduction in CENP-A and corre-
sponding H3K4 dimethlyation, causing segregation de-
fects. TRF1 and TRF2 are DNA-binding proteins in the
telomere-protecting complex shelterin, and their binding
may be influenced by the local chromatin environment
(Galati et al. 2015). Thus, without H3.3, shelterin may
not bind to the telomeres, and this would result in a
DNA damage response that leads to replicative senes-
cence or apoptosis. Contrary to our expectations, CENP-
A binding and H3K4 dimethylation levels at centromeres
increased proportionally in H3.3-depleted cells (Fig. 8E),
suggesting a counterbalancing role for H3.3 in mediating
the level of CENP-A binding and H3K4 dimethylation
in the centromere. TRF1 binding to telomeres did not
show consistent changes (Fig. 8E). To rule out nonspecific
binding of the CENP-A and TRF antibodies, we confirmed
their ChIP specificity (Supplemental Fig. S7D). We also
quantified the global levels of CENP-A, H3K4 dimethyla-
tion, and the TRF proteins in the H3.3-null and control
MEFs, and, while there appeared to be more of CENP-A
and less of the TRF proteins, the differences were not stat-
istically significant (Supplemental Fig. S7E,F).
Discussion
Our data provide an initial understanding ofH3.3 function
during mouse development. H3.3 is essential for mouse
embryogenesis, as revealed in the double-knockout and
Sox2-cKO experiments. All of the H3.3-null mutants die
in utero with severe developmental retardation. This
developmental retardation was caused in large part by
p53-mediated cell death and cell cycle arrest, as we ob-
served up-regulation of p53 targets that are directly in-
volved in these processes, and, furthermore, a p53-null
mutation effectively rescued the growth phenotype.
H3.3 appears largely dispensable for normal gene regu-
lation in embryonic development. The rare double-knock-
out mutant embryos that survived past implantation
showed correct embryonic patterning, indicated by their
mesoderm marker gene expression pattern. The Sox2-
cKO embryos, albeit still growth-retarded, also showed
correct patterning and functional cell differentiation. In
addition, when the growth retardation phenotypewas res-
cued by a p53 mutation, the Sox2-cKO–p53null embryos,
with the exception of the neural tube closure defect and
smaller size, developedwith normal body plans and gener-
ated normal structures and organs.
TheRNA-seq results provide further evidence thatH3.3
has a limited role in transcriptional regulation during
development. Although H3.3 was found enriched in all
transcribed genes (Wirbelauer et al. 2005), only ∼5% of
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Figure 8. Telomere dysfunction and heterochromatin defects in
H3.3 knockout (KO)/p53null MEFs. (A) CO-FISH results showing
normal chromosomes (panel i) and chromosomes with tSCEs,
which have either gained additional (yellow dashed circle) (panel
ii) or lost (pink dashed circle) (panel iii) FISH signals. (B) Percent-
ages of chromosomes with tSCEs in control and H3.3 knockout/
p53null MEF lines. (∗∗) P < 0.01 in χ2 test. (C,E) ChIP-qPCR results
with different antibodies and primers amplifying different repeat
sequences. (D) FAIRE (formaldehyde-assisted isolation of regula-
tory elements)-qPCR results showing increased enrichment of re-
peat sequences in H3.3 knockout MEFs normalized to littermate
control cell lines. InC–E, (∗) P < 0.05 and (∗∗) P < 0.01 in one-tailed
t-test. (F ) Model showing how loss of H3.3 affects chromosome
segregation and genome integrity. Arrows point to aberrant orga-
nized kinetochores that lead to chromosome lagging. The arrow-
head points to telomere fusion leading to the anaphase bridge.
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higher H3.3 incorporation and nucleosome turnover are
positively associated with higher transcriptional levels
(Deal et al. 2010), we expected highly transcribed genes
in the control embryos to be more significantly reduced
in double-knockout embryos. However, we did not ob-
serve an inverse correlation between fold changes and ex-
pression levels, and, surprisingly, even more genes were
up-regulated in embryos without H3.3. Whether the af-
fected genes were directly influenced by the absence of
H3.3 incorporation into them or by cellular physiological
changes altering other gene regulation mechanisms re-
mains to be determined.However, with the transcriptome
as a whole remaining largely intact without H3.3, we can
conclude that H3.3 does not play a pivotal role in tran-
scriptional regulation during mouse embryonic develop-
ment. Our finding falls in line with an observation in
H3.3-null flies, where H3.3 depletion affected relatively
very few genes during embryonic development (Hodl
and Basler 2009), although the reported compensatory
up-regulation of canonic H3 variants in H3.3 mutant flies
was not observed in the H3.3-null mouse embryos. From
an evolutionary standpoint, H3.3may have never played a
dominant role in developmental gene regulation.
On the other hand, H3.3 appears to play a major role
in maintaining genome integrity during development. In
both ES cells and MEFs, H3.3 loss caused a dramatic in-
crease of mitotic defects indicative of chromosome struc-
ture dysfunctions, including anaphase bridges and lagging
chromosomes. Prolonged nonclearance of chromosomes
at the midzone can delay mitosis and cause cleavage
furrow regression, leading to endoreplication due to non-
separation of the duplicated genome (Pampalona et al.
2012). Lagging chromosomes may fail to integrate into
the daughter nuclei and become lost, causing aneuploidy
in subsequent cell divisions (Terradas et al. 2010). Accord-
ingly, we observed a dramatic increase of polyploidy and
aneuploidy in the H3.3 knockout/p53null MEFs. The
p53-null background likely exacerbated the phenotype;
otherwise, these cells with abnormal karyotypes should
have been largely eliminated in the presence of wild-
type p53 (Aylon and Oren 2011). In addition, anaphase
bridges and lagging chromosomes in mitosis result in
DNA damage (Hayashi and Karlseder 2013), as we ob-
served increased rH2A.X levels in thesemutant cells. Kar-
yotype abnormality and DNA damage accumulation are
among the most common p53 pathway activators (Aylon
and Oren 2011; Hayashi and Karlseder 2013), conferring
on p53 the central role inmediating theH3.3-null mutant
embryonic phenotype. In conclusion, an essential func-
tion of H3.3 inmouse development is tomaintain genome
integrity by supporting functional chromosome struc-
tures, ensuring a faithful partition of replicated genomes
during cell division.
The dramatic induction of Cdkn2a upon H3.3 loss in
a p53-null background lends further support to our model
and helps explain the rescue phenotype. The two distinc-
tive proteins encoded by Cdkn2a—INK4A and ARF—are
both critical tumor suppressors, albeit acting via different
pathways (Kim and Sharpless 2006). INK4A binds CDK4/
6 and stabilizes pRB protein, while ARF inactivates the
p53 inhibitor MDM2 and thus activates the p53 path-
way. Their expression can be stimulated by DNA damage
and telomere dysfunction independent of p53 (Stott et al.
1998; Meng et al. 2003; Jacobs and de Lange 2004), and
their cell cycle inhibition function is not solely depen-
dent on p53 (Sherr et al. 2005; Britigan et al. 2014). In
the Sox2-cKO–p53null embryos, the H3.3 ablation-in-
duced telomere dysfunction and DNA damage are the
canonic biological triggers for Cdkn2 expression, and
the p53-independent cell cycle suppression mediated by
ARF and INK4A likely leads to the imperfect rescue by
the p53-null mutation that we observed; i.e., smaller
embryo size, neural tube disclosure, and the inability to
develop to term.
Epigenetic changes may be involved in the H3.3 de-
ficiency-induced mitotic chromosomal abnormalities.
The increase in tSCE is a strong indicator of compromised
telomere function (Bailey et al. 2004). The decrease in
H3K36 trimethylation at telomeres in H3.3-null cells
suggests a role for H3.3 in its maintenance. Furthermore,
we detectedmore open chromatin at the telomere, centro-
meres, and pericentromeric repeat regions in the H3.3-
null MEFs, indicating the involvement of H3.3 in hetero-
chromatin compaction. The observed increase in H3K4
dimethylation and CENP-A binding at centromeres indi-
cates abnormal changes in the centromeric chromatin
environment. The observed changes may be the cause
or, alternatively, a result of centromeric dysfunction in
H3.3-depleted cells (Sullivan and Karpen 2004). How the
lack of H3.3 as the “placeholder” for CENP-A deposition
at the centromeres leads to the abnormal changes remains
to be determined (Dunleavy et al. 2011).
Our results also suggest an intricate relationship
between the ATRX chromatin remodeling complex
and H3.3. The ATRX chromatin remodeling complex is
known to mediate H3.3 incorporation at telomeres and
pericentromeric heterochromatin (Goldberg et al. 2010),
and the embryonic Sox2-cKO phenotypes bear a striking
resemblance to that of an Atrx mutant (with Gata1-Cre-
induced global deletion at morula stage) (Garrick et al.
2006). Both H3.3 and Atrx knockouts induced growth
retardation due to reduced cell proliferation and increased
cell death without patterning defects; they even appear
highly similar morphologically. ATRX’s role in main-
taining functional chromosome structures has been
well documented. ATRX loss is associated with telomere
dysfunction in cancer cells (Heaphy et al. 2011; Lovejoy
et al. 2012). Loss of ATRX leads to centromere instability
and aneuploidy in mouse oocytes and preimplantation
embryos (Baumann et al. 2010). ATRX deficiency by con-
ditional knockouts in neuronal cell lineages or RNAi
knockdown in cultured cells induced cell death, telomere
dysfunction, and prolonged mitosis, with defects includ-
ing anaphase bridges and lagging chromosomes (Ritchie
et al. 2008; Watson et al. 2013). These are the same de-
fects that we observed in the H3.3 knockout MEFs. Fur-
thermore, the cell death/tissue growth phenotypes of
the Atrx conditional mutants can be effectively rescued
in a p53-null background (Seah et al. 2008), reminis-
cent of the rescue that we observed in Sox2-cKO–p53null
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mutants. The increased tSCE phenotype in H3.3-null
cells indicated telomere dysfunction, which is another
well-documented feature of ATRX-deficient cells (Watson
et al. 2013). All of the evidence suggests that H3.3 and
ATRX cooperate to maintain or prepare chromosome
structures for mitosis to proceed without errors. There-
fore, even though the recruitment of ATRX to telomeres
and the pericentromeric region appeared unaffected in
the absence of H3.3, active incorporation of H3.3 into
these heterochromatic structures by ATRX is essential
for its normal function at these loci.
With these lines of evidence, we propose a model in
which H3.3 maintains the histone marks and compact
structures of the heterochromatin at telomeres, centro-
meres, and pericentromeric regions by either changing
the chromatin properties through its presence at the sites
or supporting the ATRX complex that remodels chroma-
tin with repetitive sequences (Law et al. 2010). Loss of
H3.3 leads to a decrease in these essential characteristics
and disrupts the normal structure and function of telo-
meres and centromeres. The resulting telomere fusion
and centromeric abnormalities eventually lead to the
observed mitotic defects, including anaphase bridges and
lagging chromosomes (Fig. 8F).
Contrary to previous studies showing compromised vi-
ability and fertility (Couldrey et al. 1999; Bush et al. 2013;
Tang et al. 2013, 2015; Yuen et al. 2014), our single knock-
outs of H3f3a and H3f3b genes did not cause any obvious
phenotype. This may be due to genetic background differ-
ences. Themice used in our experimentswere frommixed
backgrounds (mainly C57BL/6 and 129). The increased
genetic heterogeneity may have contributed to the better
viability and fertility of our knockouts as a result of hybrid
vigor. Aside from the lack of phenotypes in the single-
knockout mutants, the distinctiveAnullBhet and AhetBnull
compound mutant phenotypes shed some light on the
evolution of the duplicated H3.3-encoding genes. There
is an obvious functional redundancy between the H3f3a
andH3f3b genes, since they encode the exact same amino
acid sequence, and loss of either one fails to produce a
phenotype. However, AHetBnull mice with only a single
wild-type H3f3a allele can survive to adulthood with
only a male infertility phenotype, while theAnullBhet mu-
tants with only a single wild-type H3f3b allele do not
survive postnatally. These phenotypical differences prob-
ably reflect changes in promoter activity (either levels or
patterns of expression) or post-transcriptional regulation
(H3f3b has isoforms with long 3′ untranslated regions
[UTRs]) of these two genes. Their differential expression
patterns in different organs also support this argument—
H3f3a has more uniform expression across organs, which
may explain why a single H3f3a allele is more supportive
to mouse life than a single H3f3b.
The disappearance of germ cells in theAhetBnull testis is
also a very interesting phenotype. Germ cells may require
more chromatin remodeling activities to maintain their
special genomic functions; e.g., erasure of parental im-
printing (Seki et al. 2005), leading tomore H3.3 incorpora-
tion to the genome. Therefore, reduction of H3.3 may
cause more dramatic transcriptional or chromosomal dis-
turbances, leading to their demise. The high demand of
H3.3 in germ cells is also reflected by the highest expres-
sion levels of both H3f3a and H3f3b genes in the testis
compared with other organs. It will require more detailed
studies to determine at what stage the germ cells are de-
pleted and the exact causes.
Materials and methods
qPCR
For gene expression analysis, total RNA was extracted with Tri-
zol (Life Technologies), treated with DNase I (Promega), and re-
verse-transcribed with ProtoScript II (New England Biolabs) and
Random primer mix (New England Biolabs). Gene-specific prim-
ers are listed in Supplemental Table S6. Pancreas tissue was first
dropped into RNAlater (Life Technologies) before further process-
ing. 18S rRNA was used as the reference gene.
For genotyping, genomic DNAwas extracted from adult tissue
by alkaline lysis method. Tissue was placed in PCR strips; heated
in 50 µL of 25 mM NaOH, 0.2 mM EDTA, and 0.04% Triton-X
100 for 1 h at 95°C; neutralized with 50 µL of 40 mM Tris-HCl
(pH unadjusted); and diluted with 100 µL of water. Extract was
cleaned by centrifugation at 3000g for 10 min. The supernatant
was used as template in qPCR reaction. For embryonic tissue, ge-
nomicDNAwas extracted by proteinase K digestionmethod. Tis-
sue was digested in 20 µL of 10 mM TE 8.0 with 0.2% Triton-X
100 and 0.4 mg/mL proteinase K (added freshly before use) over-
night at 56°C, heat-inactivated for 10 min at 95°C, diluted with
water, and cleared by centrifugation.
SsoFast reagent (Bio-Rad) and CFX384 real-time system (Bio-
Rad) were used for qPCR. qPCR reactions were run with the fol-
lowing protocol: 3 min at 95.0°C and 40 times for 10 sec at
95.0°C, 5 sec at 60.0°C, and 20 sec at 72°C per plate read. Five mi-
croliters or 10 µL of total reaction volume was used in reaction.
Mouse strains
The E14Tg2A.4 (E14) ES cell line (Skarnes 2000) was used for gene
targeting. BAC clones of 129 genetic background bMQ107m17
and mMQ457f13 (Source BioScience) forH3f3a andH3f3b genes,
respectively, were used for constructing targeting vectors. ϕC31
(Raymond and Soriano 2007) and FLPe (Farley et al. 2000) mice
were used for deleting theNeo and gene trap cassettes, respective-
ly. Primers for genotyping are listed in Supplemental Table S7.
Cell culture
For gene targeting, E14 cells were cultured in GMEM (Life Tech-
nologies) with 15% fetal calf serum (FCS), glutamine, sodium py-
ruvate, nonessential amino acids, penicillin/streptomycin, and
ESGROW/LIF (Millipore) supplements on gelatin-coated plates
without feeder.
Conditional ES cell lines were derived from blastocysts flushed
from the uterus on 3.5 d post-coitum (dpc) in crosses between
H3f3afl/fl; H3f3bfl/fl females and H3f3a−/+; H3f3b−/+; CAG-
CreERTg/0 males. They were maintained on γ-irradiated wild-
type MEF feeders. Before the H3.3 knockout/sequencing experi-
ments, they were passaged onto feeder-free plates with preplating
on gelatin-coated plates to eliminate feeder cells. TAMwas added
into culture medium at 1 µg/mL concentration and changed dai-
ly. After 2 d of TAM treatment, cells were changed back into nor-
mal medium without TAM and cultured for another day for
recovery before being harvested.
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MEFs for experiments were derived from E10.5 embryos.
Whole embryos were minced into chunks of tissue by passing
slowly through 19-gauge needles five to six times and plated on
gelatin-coated plates. They were cultured in DMEM with 10%
FCS, glutamine, sodium pyruvate, nonessential amino acids,
and penicillin/streptomycin. When MEFs that grew out from
the chunks reached confluence, they were passaged, and the tis-
sue chunks were filtered out with 100-µm cell strainers (Fisher
Scientific).
Whole-mount in situ hybridization
We followed the standard protocol for whole-mount in situ hy-
bridization (Nagy 2003). Embryos were fixed in 4% paraformalde-
hyde (PFA) and hybridized with probe labeled with digoxigenin-
11-UTP (Roche). Full-length cDNA of Brachyury was used as
the template for probe synthesis. An anti-Dig-AP Fab (Roche)
fragment and BM Purple (Roche) were used for detection and vi-
sualization of the hybridized probe.
Lysotracker staining
For Lysotracker staining, we follow the protocol as previously
described (Fogel et al. 2012). Embryos were dissected in HBSS
(Life Technologies), stained with LysoTracker Red DND-99
(Life Technologies), fixed in 4% PFA, cleared in 50% glycerol,
and imaged.
BrdU labeling
Pregnant females were intraperitoneally injected with 50 mg/kg
BrdU 3 h before being euthanized and having embryos dissected
out. Embryos were fixed, sucrose-protected, and frozen-sec-
tioned, antigen-retrieved by heating for 5 min to 85°C in 75%
formamide/PBS, and detected with anti-BrdU antibody (1:200
dilution; Abcam, BU1/75 ICR1).
Western blot
Whole histone preparations were extracted by acid extraction as
described (Shechter et al. 2007). Proteins were separated on
12.5% SDS-PAGE and detected with anti-H3.3 (1:40 dilution;
Abnova, 2D7-H1), anti-H3 (1:10,000; Abcam, ab1791), and anti-
rH2A.X (1:1000; Cell Signaling Technology, 20E3) antibodies;
anti-H3K9 dimethylation (1:1000; Abcam, ab1220); anti-H3K9
trimethylation (1:1000; Abcam, ab8898); and anti-H3K79 dime-
thylation (1:1000; Abcam, ab3594).
FISH and immunofluorescence
Cells were grown on gelatin-coated coverslips, fixed with 4%
PFA, in situ-hybridized with Alexa 488-conjugated TelC PNA
oligo (PNA Bio, Inc.) following the manufacturer’s instructions
(except omitting RNase/pepsin treatments) and ethanol dehydra-
tion steps, and then immunostained with anti-ATRX primary
(Santa Cruz Biotechnology, H-300) and then Alexa 568-conjugat-
ed secondary antibodies. Z-stack images were deconvolved and
flattened by maximal intensity projection with AxioVision soft-
ware (Carl Zeiss).
Metaphase spreads and CO-FISH
Cells were treated with KaryoMax (Life Technologies) for 4 h,
trypsinized, hypotonized in 75mMKCl for 10min, fixed inmeth-
anol with glacial acetic acid (5:2) overnight or longer at 4°C,
dropped on distilled water-flooded uncoated slides, stained with
DAPI, and imaged, and chromosomes were counted.
For CO-FISH, we followed the previously described protocol
(Williams et al. 2011). Alexa 488-conjugated TelC PNA oligos
(PNA Bio, Inc.) were used in hybridization. For scoring the tSCE
phenotype, FISH signalswere scored blind for statistical analyses.
Comparable numbers of chromosomes (from 20–50 spreads) were
scored for each pair of sibling MEF lines.
ChIP-qPCR
For histone ChIP, we followed the previously described protocol
(Schmidt et al. 2009) with specific details as follows. Cells were
fixed with 0.6% formaldehyde for 10 min at room temperature.
Chromatin shearing was carried out in LB3 in 15-mL clear tubes
with Bioruptor (Diagenode), with two rounds of six cycles of 30-
sec pulses (high) and 1-min breaks separated by a 10-min cool
down on ice. Protein A/G+ agarose beads (Santa Cruz Biotechnol-
ogy, sc-2003) were used. Antibodies were the same ones used in
the Western blotting.
For Atrx ChIP, cells were fixed as previously described (Law
et al. 2010). ChIP was carried out following the previously
described MNase protocol (Kouskouti and Talianidis 2005)
except omitting the sucrose gradient extraction step. Protein
A/G Dynabeads (Life Technologies) were used. Anti-Atrx (Santa
Cruz Biotechnology, H-300) and control rabbit IgG (Sigma,
I5006) antibodies were used.
Primers for quantification of major/minor satellite and telo-
mere repeat sequences are listed in Supplemental Table S6.
FAIRE
For FAIRE, we followed the previously described protocol (Simon
et al. 2013). Cell fixation and chromatin shearing conditions
were the same as in ChIP. Primer pairs are list in Supplemental
Table S6.
RNA-seq
The RNA-seq library was prepared with KAPA stranded mRNA-
seq kit (KapaBiosystems, catalog no. KK8420), following theman-
ufacturer’s instructions, for 6 min at 85°C at the RNA fragmenta-
tion step. Total RNA was extracted from embryos with Trizol,
DNase I-digested, and cleaned upwithRNeasy columns (Qiagen).
RNA samples (0.5 µg) were used for library generation. Libraries
were pooled (four per lane) and sequenced by Illumina HiSeq
2500 sequencer. The RNA-seq FASTQ files were aligned to
the UCSC mm9 genome using TopHat2 (Trapnell et al. 2009)
and Bowtie2 (Langmead and Salzberg 2012) using the iGenomes
reference sequences (http://support.illumina.com/sequencing/
sequencing_software/igenome.ilmn) and annotations provided
by Illumina. Annotation for REs came fromRepeatMasker down-
loaded from the UCSC Genome Browser. Read counts per
gene and RE were generated using HTSeq-count (http://www-
huber.embl.de/users/anders/HTSeq/doc/count.html), and differ-
ential expression analysis was performed using edgeR (Robinson
et al. 2010). Normalized BEDGraph files for UCSC genome
browser tracks were generated using BEDTools (Quinlan and
Hall 2010).
Data access
The RNA-seq data have been deposited in NCBI’s Gene Expres-
sion Omnibus and are accessible through GEO series accession
number GSE69771 (http://www.ncbi.nlm.nih.gov/geo/query/acc
.cgi?acc=GSE69771).
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